“Given the need to ensure that only high quality stocks with sufficient market depth are allowed to trade in derivatives segment and considering the growth witnessed in market parameters since the last review conducted in 2018, the eligibility criteria for entry and exit of stocks in derivatives segment has been revised,” Sebi said in a circular on Friday.
Right time to take profit off the table in pharma; defence a structural buy: Rajiv Batra
Rajiv Batra addresses global investors’ concerns about India’s growth and policy, emphasizing the need for double-digit earnings and nominal GDP growth to reignite foreign investor